Article: NAC: Stanford San Francisco Study Report Shows Blood Glutathione Improvement, Possible Survival Benefit.

[Disclosure: The senior authors of the NAC study reported here, Drs. LA Herzenberg, both Ph.D., of the Department of Genetics at Stanford University, are on the board of AIDS Treatment News Associates, our nonprofit arm which helps fund newsletter subscriptions for prisoners, persons with low income, and others who cannot pay for copies. The Herzenbergs have a use patent for NAC in the treatment of HIV infection, and have pledged any proceeds to further research.]

A placebo-controlled trial in over 60 HIV-positive volunteers found that NAC (Nacetylcysteine) significantly increased abnormally low blood and T-cell levels of glutathione, an important antioxidant ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!